Fiasp is a medicine that is used to treat children from one year of age and adults with diabetes. It contains the active substance insulin aspart, a rapid-acting insulin.
Therapeutic Indication
### Therapeutic indication Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
Therapeutic Area (MeSH)
ATC Code
A10AB05
ATC Item
insulin aspart
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| insulin aspart | N/A | 门冬胰岛素 |
EMA Name
Fiasp
Medicine Name
Fiasp
Aliases
N/ANo risk management plan link.
